CPD Courses

NEW Safety Data on Testosterone Therapy for Men

Webinar Androlabs

About the CPD course

Dr. Channa Jayasena provides an overview of the most recent safety data concerning the cardiovascular risks associated with testosterone replacement therapy in male hypogonadal patients. Drawing from the latest TestEs and TRAVERSE data; he shares key insights and considerations from current research; shedding light on how this new information enhances our understanding of the cardiovascular safety of testosterone replacement therapy.

CPD Provider

Androlabs

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Androlabs

Androlabs

A men's health pharmaceutical company. 

Want to learn more?

Get industry-related content straight to your inbox

By signing up to our site you are agreeing to our privacy policy